Nabila Gala Nacul Mora

University Hospital Münster

Papers

1

Total Citations

6

H-Index

1

About

Nabila Gala Nacul Mora is a clinical researcher whose work focuses on the intersection of surgical oncology and patient physiology, particularly in esophageal cancer. Her key research areas include sarcopenia, minimally invasive surgical outcomes, and perioperative risk stratification. She is best known for her landmark 2025 study, "Sarcopenia worsens overall survival following robotic esophagectomy for esophageal cancer," which has already garnered 6 citations—a strong early impact for a recent publication. In this work, Mora demonstrated that sarcopenia is an independent risk factor for poor survival in esophageal cancer patients undergoing robotic esophagectomy, highlighting how preoperative muscle wasting can significantly compromise surgical outcomes. Her findings underscore the importance of integrating nutritional and functional assessments into preoperative planning. By identifying sarcopenia as a modifiable prognostic factor, Mora’s research provides actionable insights for improving patient selection and perioperative care. Her work is particularly relevant for surgeons and oncologists seeking to optimize outcomes in high-risk populations, and it positions her as an emerging voice in the field of cancer cachexia and surgical recovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Sarcopenia worsens overall survival following robotic esophagectomy for esophageal cancer
6 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: University Hospital Münster

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago